Literature DB >> 8116572

Immunohistochemical study of p53 in gastric carcinoma.

M Fukunaga1, T Monden, H Nakanishi, M Ohue, K Fukuda, N Tomita, T Shimano, T Mori.   

Abstract

The authors had previously reported that the accumulation of p53 is clearly demonstrable in microwave-fixed, paraffin-embedded sections of colorectal carcinomas. In the present paper, the authors performed an immunohistochemical study of p53 in gastric carcinomas prepared by microwave irradiation. Using a monoclonal antibody (PAb1801), nuclear p53 was detected in 22 of 45 (49%) cases of gastric carcinoma, and no staining for p53 was demonstrated in the adjacent normal epithelium, including areas of intestinal metaplasia. The incidence of p53 accumulation was not affected by clinical features, such as tumor stage, depth of invasion, and metastasis; however, positivity for p53 was significantly higher in intestinal-type carcinomas (56%) than in diffuse-type (27%) carcinomas. Furthermore, a large number of carcinoma cells expressed p53 in the intestinal-type, but only a few cells were positive for p53 in the diffuse-type. The results of the present immunohistochemical study of p53 accumulation in gastric carcinomas suggest that gene alterations of p53 are not rare in gastric carcinomas and may participate in the carcinogenesis of intestinal-type carcinomas of the stomach.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116572     DOI: 10.1093/ajcp/101.2.177

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  "Crawling-type" adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma.

Authors:  Naoko Okamoto; Hiroshi Kawachi; Tatsuya Yoshida; Keisuke Kitagaki; Masaki Sekine; Kazuyuki Kojima; Tatsuyuki Kawano; Yoshinobu Eishi
Journal:  Gastric Cancer       Date:  2012-08-04       Impact factor: 7.370

2.  Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.

Authors:  M Salih Deveci; Güzin Deveci
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

3.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval.

Authors:  E Evke; F Z Minbay; S G Temel; Z Kahveci
Journal:  J Mol Histol       Date:  2008-12-19       Impact factor: 2.611

5.  Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma.

Authors:  Mohammad Reza Zali; Omeed Moaven; Hamid Asadzadeh Aghdaee; Kamran Ghafarzadegan; Khadijeh Jami Ahmadi; Mehdi Farzadnia; Azadeh Arabi; Mohammad Reza Abbaszadegan
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

6.  Allelotype analysis of adenocarcinoma of the gastric cardia.

Authors:  C M Gleeson; J M Sloan; J A McGuigan; A J Ritchie; J L Weber; S E Russell
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The prognostic value of UHRF-1 and p53 in gastric cancer.

Authors:  Nalan A Babacan; Hatice Reyhan Egilmez; Birsen Yücel; Parlak Ilknur; Mehmet Metin Seker; Turgut Kacan; Aykut Bahceci; Sener Cihan; Bülent Akinci; Berna Eriten; Saadettin Kilickap
Journal:  Saudi J Gastroenterol       Date:  2016 Jan-Feb       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.